Manufacturer:
Bristol Myers Squibb
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- treatment of locally advanced squamous cell carcinomas of the head and neck, (excluding lip) in combination with concurrent chemoradiation
Conditions:
- Chronic Myeloid Leukemia
- Squamous Cell Carcinoma
- Sickle Cell Disease
Therapeutic Area:
- Oncology